Anand B. Karnad

6.8k citations
75 papers · 2.5k indexed · 1 hit paper · h-index 24

Anand B. Karnad

73 papers receiving 2.4k citations

Hit Papers

The biology and role of CD44 in cancer progression: thera...9382018202620202023250500750

Peers

Anand B. Karnad
Comparison fields: 5 of 135
  • Oncology 1.0k
  • Otorhinolaryngology 129
  • Cancer Research 351
  • Cell Biology 254
  • Hematology 141
Replace Ralph Weichselbaum with:
Ralph Weichselbaum United States
Marleen Praet Belgium
Edward Kim United States
Ingo B. Runnebaum Germany
Alfonso Dueñas‐González Mexico
Sepp Leodolter Austria
Masami Fujita Japan
Sam M. Wiseman Canada
Kyong Hwa Park South Korea
Thomas M. Behr Germany
Anand B. Karnad relative to Ralph Weichselbaum United States Ralph Weichselbaum's profile →
Citations per field
00.5×1.5×2.4×
Ralph Weichselbaum · 1×
Citations per year

Countries citing papers authored by Anand B. Karnad

Since Specialization
Citations

This map shows the geographic impact of Anand B. Karnad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anand B. Karnad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anand B. Karnad more than expected).

Fields of papers citing papers by Anand B. Karnad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anand B. Karnad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anand B. Karnad. The network helps show where Anand B. Karnad may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Anand B. Karnad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anand B. Karnad Line = papers co-authored together Anand B. Karnad links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20242
2 20241
3 202229
4 202163
5 201817
6 201627
7 201634
8 20159
9 201315
10 201311
11 20122
12 201040
13 200714
14 200762
15 20031
16 20032
17 199745
18 19925
19 19914
20 19901

About Anand B. Karnad

Anand B. Karnad is a scholar working on Otorhinolaryngology, Oncology and Geriatrics and Gerontology, having authored 75 papers that have together received 2.5k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (6 papers), Cancer Genomics and Diagnostics (5 papers), Head and Neck Cancer Studies (5 papers), Economic and Financial Impacts of Cancer (5 papers), Lung Cancer Treatments and Mutations (5 papers), Global Cancer Incidence and Screening (4 papers), Colorectal Cancer Treatments and Studies (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). The work is most often cited by research in Oncology (1.0k citations), Otorhinolaryngology (129 citations) and Cancer Research (351 citations). Anand B. Karnad has collaborated with scholars based in United States, Greece and United Kingdom. Frequent co-authors include James W. Freeman, Shujie Zhao, Chen Chen, Scott A. Soefje, Andrew Brenner, Guha Krishnaswamy, Alan N. Peiris, Addanki P. Kumar, David H. Hussey and Randal A. Otto. Their work appears in journals such as Journal of Clinical Oncology, Blood and Annals of Internal Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026